Product Information
KETOROLAC 30 MG/ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.8790 per ML under NDC 00641604225. Its NADAC has been published 370 times since May 18, 2016.
Strength
30 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641604225
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA075772On Market Since
7/21/2004
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 30 MG/ML VIAL has been published 370 times since May 18, 2016, and over the history we have for it it has declined 59.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8790 per ML |
|---|---|
| All-time high | $4.1276 (Aug 31, 2016) |
| All-time low | $0.7047 (Mar 18, 2026) |
| 52-week high | $1.2435 |
| 52-week low | $0.7047 |
| Median price | $1.3574 |
| Average price | $1.3896 |
| Largest weekly change | +94.7% (Aug 17, 2016) |
| Weeks tracked | 370 |
| Tracking since | May 18, 2016 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of KETOROLAC 30 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 30 MG/ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.8790 per ML (NDC 00641604225), effective Jun 24, 2026.
How has the price of KETOROLAC 30 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for KETOROLAC 30 MG/ML VIAL has declined 59.7%. It has been tracked across 370 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for KETOROLAC 30 MG/ML VIAL?
Since May 18, 2016, the NADAC for KETOROLAC 30 MG/ML VIAL has ranged from a low of $0.7047 (Mar 18, 2026) to a high of $4.1276 (Aug 31, 2016), with a median of $1.3574 per ML.
Are there cheaper alternatives to KETOROLAC 30 MG/ML VIAL?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, KETOROLAC 60 MG/2 ML VIAL, is $0.4988 per ML — about 43% below KETOROLAC 30 MG/ML VIAL.
Who manufactures KETOROLAC 30 MG/ML VIAL?
KETOROLAC 30 MG/ML VIAL (NDC 00641604225) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification